Surrex Consulting

Application Infrastructure

Device42 | April 28, 2022

Device42, the most comprehensive agentless hybrid IT discovery, inventory and asset management solution, today announced its new Insights+ Platform designed to help organizations gain critical IT visibility needed to manage today’s growing complex IT environments. The company historically has provided advanced discovery and inventory capabilities, and today it is launching Insights+, designed to further increase operational efficiency, visibility, with access to powerful insights. Insights...

Hyper-Converged Infrastructure, Application Infrastructure

businesswire | May 31, 2023

Edgecore Networks, a leading provider of traditional and open network solutions for enterprises, data centers, and telecommunication service providers, is pleased to announce the launch of its newest high-performance enterprise product family, the EPS120 Series. These optimized 1Gbps open switches are ideal for large retailers, campuses, and enterprise branches, offering robust 1G switching performance with high data transmission bandwidth and a large packet buffer to absorb traffic bursts...

IT Systems Management

Synaptics | February 23, 2022

Synaptics Incorporated announced the opening of a wireless research and development center in the Sophia Antipolis technology park in southeast France. Focused on Wi-Fi and Bluetooth hardware and software development, the facility will serve as a hub for the design of Synaptics’ next-generation short-range wireless connectivity for the Internet of Things (IoT). “Our wireless connectivity technology is an essential differentiator for us as we continue to expand into hig...

Hyper-Converged Infrastructure, Application Infrastructure

Elucidata | September 27, 2022

Elucidata, a TechBio company that powers life science research & development (R&D) with its data-centric Machine Learning Operations (ML-Ops) platform, Polly, announced that it has raised $16 million in a Series A fundraising today. The round was led by leading global investment firm Eight Roads Ventures, with participation from F-Prime Capital, IvyCap Ventures, and Hyperplane Venture Capital. The newly infused capital will be used to deepen product capabilities in translational drug res...